UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14D-9
(Rule 14d-101)
Solicitation/Recommendation Statement
Under Section 14(d)(4) of the Securities Exchange Act of 1934
GENMARK DIAGNOSTICS, INC.
(Name of Subject Company)
GENMARK DIAGNOSTICS, INC.
(Name of Persons Filing Statement)
Common Stock, par value $0.0001 per share
(Title of Class of Securities)
372309104
(CUSIP Number of Class of Securities)
Scott Mendel
Chief Executive Officer
GenMark Diagnostics, Inc.
5964 La Place Court
Carlsbad, CA 92008
(760) 448-4300
(Name, address and telephone numbers of person authorized to receive notice and communications
on behalf of the persons filing statement)
With a copy to:
Michael Kagnoff, Esq.
Patrick O’Malley, Esq.
4365 Executive Drive, Suite 1100
San Diego, CA 92121
(858) 677-1400
| ☒ | Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer. |
The information set forth under Items 7.01 and 9.01 of the Current Report on Form 8-K filed by GenMark Diagnostics, Inc. on March 15, 2021 (including all exhibits attached thereto) is incorporated herein by reference.
